Trial intelligence / Profile preview

Levetiracetam plus sodium valproate vs sodium valproate on interictal epileptiform discharges in children

IRCT20120215009014N246Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of levetiracetam and valproic acid in epilepsy (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Change in epileptiform discharges on interictal EEG. Started Jun 2018; status: completed.

02

Drugs

levetiracetamvalproic acid
03

Conditions

epilepsy

Beyond the preview

Go deeper on IRCT20120215009014N246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call